PLEASANTON, Calif.—Samsung Electronics Co. and IrisVision, a leader in digital vision technologies and maker of the world's first smart, wearable vision-assistive device, announced a strategic partnership to roll out IrisVision's groundbreaking technology worldwide. IrisVision's vision correction software platform utilizes the power of Samsung's industry leading Galaxy smartphones and XR devices and mobile AI platform to enable people with impaired vision to see clearly and live more independent lives, according to the announcement on Tuesday.

The goal of the partnership is to enable expansion of IrisVision’s proprietary vision correction platform into new therapeutic, diagnostic and telehealth applications

Within the partnership, IrisVision will continue to work with Samsung's R&D and alliance partnership teams to further expand the use of Samsung technologies, including 5G mobile phones, Bixby AI platform and XR headsets. Also, Samsung will help IrisVision scale connected health care for the visually impaired community.

IrisVision launched its new technology in 2017 and received registration as an FDA Class I medical device that same year. Over the past two years, the company has run clinical trials with Johns Hopkins, Stanford and UPMC, and the company continues to extend its proprietary vision correction science to address more than 16 common eye conditions. These include macular degeneration, diabetic retinopathy and retinitis pigmentosa.

IrisVision already has thousands of users around the world and received a CES 2019 Innovation Award recognizing its technology and customer success.

"At Samsung, we aim to not only build great mobile solutions but also to give our key partners mobile technology platforms to develop and provide their own innovation,” Edward Choi, corporate vice president of global strategic alliances in the mobile communications division of Samsung Electronics, said in the announcement. “It is amazing to see what IrisVision is doing to enable the large and underserved low vision community to live more independently. We will help guide IrisVision on technology integration and market strategy to ultimately help every affected patient."

"Our vision science requires substantial computational power, quality optics, and a platform we can use to securely connect patients to providers and the digital world, all of which Samsung's mobile and XR devices provide today," IrisVision chief executive officer and co-founder Ammad Khan added. "With this partnership, Samsung's technology and support, along with its global channels and partner network, will also enable the next generation of IrisVision products to diagnose and treat conditions remotely anywhere in the world."